NAVER D2SF Invests in AI Nutrition Startup Nuvilab

NAVER D2SF, the venture capital arm of South Korean tech giant NAVER, has deepened its commitment to Nuvilab, an artificial intelligence startup focused on nutrition analytics. This follow-on investment, part of Nuvilab's Series A bridge funding, underscores the investor's confidence in the company's innovative approach to healthcare data and its burgeoning presence in the North American market.

Nuvilab has pioneered a sophisticated system that leverages image recognition and AI to provide real-time analysis of food intake and nutritional content. By integrating scanners into daily environments like hospitals, schools, and childcare facilities, the company facilitates effortless, passive data collection. This user-friendly methodology has resulted in an impressive 95% user retention rate, a significant benchmark in the often-challenging healthcare sector. The technology is powered by a robust multimodal AI model, trained on an extensive dataset exceeding 100 million food entries, achieving remarkable 98% accuracy in under a second.

The company, which initially validated its product in South Korea's business-to-business and government sectors, is now aggressively pursuing growth in the United States healthcare system. Nuvilab is actively refining its platform to boost efficiency in hospital patient care and is rapidly expanding its client roster. By the close of 2025, the startup had amassed over 1,000 corporate clients globally and served 100,000 active users. A key strategic move includes a recent exclusive partnership with a major international catering conglomerate to deploy its solutions across U.S. hospitals.

Evidence of Nuvilab's impact is particularly strong in hospital food safety management. Pilot programs have demonstrated that its AI-driven solution can reduce meal service errors by 49% and cut food preparation timelines by 23% when compared to traditional manual oversight. These tangible improvements are paving the way for broader applications, including advanced dietary intake tracking and potential integrations with health insurers and pharmaceutical firms, tapping into the growing digital health market which is projected to reach hundreds of billions of dollars in the coming years.

“Dietary habits, while fundamental to health, have historically been difficult to quantify and integrate into care pathways,” stated Logan Kim, CEO of Nuvilab. “Our mission is to bring structure to this vital data using AI, ultimately establishing a new standard in global healthcare.”

Sanghwan Yang, Head of NAVER D2SF, commented on the investment, noting, “Nuvilab has rapidly demonstrated product-market fit in North America, building upon its established technological capabilities and business acumen from Korea. We remain committed to supporting ambitious startups that target global markets and exhibit strong growth trajectories.” This investment aligns with NAVER D2SF's strategy of backing innovative companies that leverage AI to address significant real-world challenges.